Insulin growth factor 1 increases vascular smooth muscle nitric oxide production

Life Sciences

Volumn 61, Issue 9, 1997, Pages 925-931

  Muniyappa, R ^a   Walsh, M F ^a   Rangi, J S ^a   Zayas, R M ^a   Standley, P R ^a   Ram, J L ^a   Sowers, J R ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aminoguanidine; IGF 1; Nitric oxide; Vascular smooth muscle cells

Indexed keywords

AMINOGUANIDINE; CYCLOHEXIMIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SOMATOMEDIN C;

ANIMAL CELL; AORTA; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG INHIBITION; DRUG MECHANISM; ENZYME INDUCTION; NONHUMAN; PROTEIN SYNTHESIS; RAT; REGULATORY MECHANISM; SMOOTH MUSCLE FIBER; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA; CELLS, CULTURED; CYCLOHEXIMIDE; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; GUANIDINES; INSULIN-LIKE GROWTH FACTOR I; KINETICS; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN SYNTHESIS INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; STIMULATION, CHEMICAL;

ANIMALIA;

EID: 0030877286     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(97)00594-8     Document Type: Article

References (23)

1. P.R. STANDLEY, Z. ZHANG, J.L. RAM, J.R. SOWERS. J Clin. Invest. 88 1230-1236 (1991).
2. J.R. SOWERS. Diabetes 45 S47-S51 (1996).
3. S. YAGI, S. TAKATA, H. KIYOKAWA, M. YAMAMOTO, Y. NOTO, T. IKEDA, N. HATTORI. Diabetes.37 1064-1067 (1988).
4. J.L. RAM, M.A. FARES, P.R. STANDLEY, J.R. SOWERS. J Vasc. Biol. 4 250-254 (1993).
5. G. LEMBO, G. IACCARINO, V. RENDIKA, M. VOLPE, B. TRIMARCO. Hypertension 24 429-438 (1994).
6. K.C. COPELAND and K. SREEKURAN. J. Clin. Endocrinol. Metab. 79 230-232 (1994).
7. U. SCHERRER, D. RANDIN, P. VOLLENWEIDER, L. VOLLENWEIDER, P. NICOD. J Clin. Invest. 94 2511-2515 (1994).
8. H.O. STEINBERG, G. BRECHTEL, A. JOHNSON, N. FINEBERG, A.D. BARON. J Clin. Invest 94 1172-1179 (1994).
9. M.F. WALSH, M. BARAZI, G. PETE, R. MUNIYAPPA, J.C. DUNBAR, J.R. SOWERS. Endocrinology. 137 1798-1803 (1996).
10. H. TSUKAHARA, D.V. GORDIENKO, B. TONSHOFF, M.C. GELATO AND M.S GOLIGORSKY. Kidney International 45 598-604 (1994).
11. P.R. STANDLEY, J.L. RAM, J.R. SOWERS. Endocrinology 133 1693-1699 (1993).
12. L.C. GREEN, D.A. WAGNER, J. GLOGOWSKI, P.L. SKIPPER, J.S. WISHNOK, AND S.R. TANNENBAUM. Anal.Biochem.126 131-138 (1982).
13. M.J.D. GRIFFITH, M. MESERNT, R.J. MACALLISTER AND T.W. EVANS. Br. J. Pharmacol. 110 963-968 (1993).
14. D.A. FRYBERG. J. Clin. Invest. 97 1319-1328 (1996).
15. G.J. SOUTHAN and C. SZABO. Biochemical Pharmacology 51 383-394 (1996).
16. D.J. WOLFF and A. LUBESKIE. Arch. Biochem. Biophys. 316 290-301 (1995).
17. V.B. SCHINI, S. CATOVSKY, B. SCHRAY-UTZ, R. BUSSE, P.M. VANHOUTTE. Circ. Res.74 23-32 (1994).
18. M. TROVATI, P. MASSUCCO, L. MATTIELLO, F. CAVALOT, E. MULARONI, A. HAHN. G. ANFOSSI. Diabetologia 38 936-941 (1995).
19. W.W. SIMMONS, E.I. CLOSS, J.M. CUNNIGHAM, T.W. SMITH and R.A. KELLY. J Biol. Chem. 271 11694-11702 (1996).
20. I. JORIS, E. STETZ, and G. MAJNO. Atherosclerosis 34 221-231 (1979).
21. J. RAVI, C.S. MANTZOROS, A.S. PRABHU, J.L. RAM, J.R. SOWERS. Am. J. Hypertens. 7 1065-1069 (1994).
22. G.A. JOLLY, M. AYRES, F. CHELLY, R.G. KILBOURN. Biochem. Biophys. Res.Commun.199 147-54 (1994).
23. A. CITTADINI, H. STROMER, S.E. KATZ, R. CLARK, A.C. MOSES, J.P. MORGAN, P.S. DOUGLAS. Circulation 93 800-809 (1996).